These lines of evidence also suggest that tumoral-PAFR expression could directly modulate the in vivo tumor growth via inducing systemic immunosuppressive effects mediated by more enzymatic PAF production by positive feed-forward mechanisms. Here, PCLAF is linked to neoplasm.